New insider activity at Merit Medical Systems ( (MMSI) ) has taken place on March 7, 2025.
In recent transactions involving Merit Medical Systems stock, significant sales were made by key executives. CLO and Secretary Brian G. Lloyd sold 30,000 shares, amounting to $3,087,000. CFO and Treasurer Raul Jr. Parra sold 5,361 shares, totaling $555,292. Meanwhile, President and CEO Fred Lampropoulos sold 34,319 shares, with the sale valued at $3,563,992.
Recent Updates on MMSI stock
Merit Medical Systems recently reported strong Q4 earnings, showcasing significant revenue growth and record profitability, driven by effective cost management and operational efficiency. The company also highlighted successful acquisitions and robust free cash flow, although it faces challenges in international sales, particularly in the EMEA and China regions, and increased operating expenses. Despite the positive earnings report, several analysts have lowered their price targets for Merit Medical. The primary reasons for these adjustments include lighter-than-expected full-year 2025 earnings guidance, higher interest expenses, and dilution related to convertible debt. Analysts remain optimistic about the company’s strategic execution and continued growth prospects, maintaining positive ratings despite the price target reductions.
More about Merit Medical Systems
YTD Price Performance: 9.14%
Average Trading Volume: 553,707
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $5.99B
Questions or Comments about the article? Write to editor@tipranks.com